Sandmartin Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 42.41%
- Profit Growth 19.22%
- Ebitda 2674.79%
- Net Worth 15.98%
- Total Assets 198.63%
About Sandmartin Pharmaceuticals
Sandmartin Pharmaceuticals Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 February 2016 (Eight years and 11 months 21 days old ). Its registered office is in East Delhi, Delhi, India.
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Ritesh Kumar and Arvind Singh serve as directors at the Company.
Company Details
-
Location
East Delhi, Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74999DL2016PTC291641
-
Company No.
291641
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Feb 2016
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Sandmartin Pharmaceuticals Private Limited offer?
Sandmartin Pharmaceuticals Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Nutraceuticals & Dietary Supplements, Mineral Supplement, Pain Relief Drugs & Pharmaceuticals, Antipyretic Medication, Cardiovascular Drugs & Medication, Kidney Drugs, Common Disease Medicines, Antihistamines.
Who are the key members and board of directors at Sandmartin Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ritesh Kumar
|
Director | 24-Feb-2016 | Current |
|
Arvind Singh
|
Director | 08-Apr-2016 | Current |
Financial Performance of Sandmartin Pharmaceuticals.
Sandmartin Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 42.41% increase. The company also saw a substantial improvement in profitability, with a 19.22% increase in profit. The company's net worth Soared by an impressive increase of 15.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sandmartin Pharmaceuticals?
Unlock access to Sandmartin Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sandmartin Pharmaceuticals?
Unlock and access historical data on people associated with Sandmartin Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sandmartin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sandmartin Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
